Neurostimulation Devices Market size worth $13.7bn by 2023 - PowerPoint PPT Presentation

Loading...

PPT – Neurostimulation Devices Market size worth $13.7bn by 2023 PowerPoint presentation | free to download - id: 838b36-OWE4M



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Neurostimulation Devices Market size worth $13.7bn by 2023

Description:

Neurostimulation Devices Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2016 - 2023 – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Neurostimulation Devices Market size worth $13.7bn by 2023


1
Neurostimulation Devices Market size worth
13.7bn by 2023, at over 14.5 CAGR Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Neurostimulation Devices Market
  • Global neurostimulation devices market size
    estimates were USD 4.58 billion in 2015, and
    forecast to attain CAGR of 14.7 up to 2023 and
    exceed USD 13.5 billion.
  • Spinal cord stimulation products dominate the
    global market, with over USD 2.6 billion revenue
    in 2015 these were among the earliest
    commercialized technologies in the industry and
    thus enjoy strong penetration.
  • Gastric electric stimulation deep brain
    stimulation devices are also perceived to be
    attractive avenues for growth. However, the
    nascent nature of these technologies leaves room
    for further investigation and RD. These niche
    segments may lead to a rise in RD spending and a
    dynamic IP landscape.

3
Continued...
  • Europe neurostimulation device market revenue is
    set to exceed USD 2.8 billion by 2023, at 16.6
    CAGR.
  • Pain management application segment was estimated
    at USD 3.05 billion in 2015. This market size can
    be attributed to rising global chronic pain
    disorder prevalence along with growing
    neurostimulation device adoption for pain
    management due to strong therapeutic value.
  • The threat of new entry in the market is low,
    mainly due to capital intensive nature of the
    market. Moreover, the companies entering this
    market need high capital investments to set up
    manufacturing and research development
    facilities.

4
Continued...
  • Neurostimulation devices play an important role
    in providing therapeutic solutions for depression
    and obesity and therefore a rise in the
    prevalence of such diseases is expected to drive
    demand.
  • Minimally invasive transdermal neuromodulation
    technology by Neurowave and MRI safety
    incorporated devices by Medtronic will drive
    industry innovation. Rapid economic development
    in APAC and LATAM will strengthen the platform
    for the growth of this market by enhancing buying
    power of consumers.

5
Europe neurostimulation devices market Size, by
product, 2014-2023, (USD Million)

6

Browse Full Market Research Report On
Neurostimulation Devices Market _at_
http//goo.gl/sv1iT3 Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/436 https//www.gminsight
s.com/request-sample/detail/49
7
360 Analysis
  • Product Analysis
  • Spinal cord stimulator is a predominant product
    segment, generating over 57 of neurostimulation
    market size in terms of revenue in 2015, on
    virtue of being one of the earliest technologies
    to be commercially available, hence gaining
    maximum market penetration.
  • Regional Analysis
  • North America, dominated by the U.S.
    neurostimulation devices market size is forecast
    to exceed USD 7.6 billion by 2023, still
    remaining the largest regional industry. Rapid
    adoption of advanced technologies, high
    prevalence of target diseases such as epilepsy,
    Parkinsons disease, and incontinence, coupled
    with increased awareness levels are key driving
    factors.
  • Competitive Market Share
  • Global neurostimulation devices market share is
    led by Medtronic, Inc. St. Jude Medical, which
    accounted for approximately 65 share in 2015.
    Other active players in this market include
    Boston Scientific Corporation, Cyberonics, Nevro
    Corporation, and Neuronetics, Inc. among others.
    Acquisitions and strategic alliances is the major
    strategy adopted by the players in this market,
    in order to maintain leadership position.

8
Stay In Touch Website www.gminsights.com Soci
al Media
About PowerShow.com